Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting

BACKGROUND: Despite the current recommendation for influenza vaccination in cancer patients with active oncological therapy, limited data are available on the efficacy of vaccination in cancer patients receiving targeted therapies. We aimed to investigate the immunogenicity and tolerability of influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Joona, Therse Björkin, Digkas, Evangelos, Wennstig, Anna-Karin, Nyström, Karin, Nearchou, Andreas, Nilsson, Cecilia, Pauksens, Karlis, Valachis, Antonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568724/
https://www.ncbi.nlm.nih.gov/pubmed/32737713
http://dx.doi.org/10.1007/s10549-020-05815-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568724/
https://www.ncbi.nlm.nih.gov/pubmed/32737713
http://dx.doi.org/10.1007/s10549-020-05815-y

Ejemplares similares